BRADY BLACKHAM: Open Payments
NPI 1679701197 · GUNNISON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 12 payments from 5 companies in 2025. Trend: 2023 $567 · 2024 $402 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $92 |
| Supernus Pharmaceuticals, Inc. | 3 | $83 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Lilly USA, LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Qelbree, VRAYLAR, QULIPTA, MOUNJARO, JARDIANCE, ROTATEQ, GARDASIL 9.
Industry payments across UT — which companies pay providers there.
